Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality

Nature Genetics

Volumn 48, Issue 12, 2016, Pages 1557-1563

  Eppinga, Ruben N ^a   Hagemeijer, Yanick ^a   Burgess, Stephen ^b   Hinds, David A ^c   Stefansson, Kari ^d,e   Gudbjartsson, Daniel F ^d,e   Van Veldhuisen, Dirk J ^a   Munroe, Patricia B ^f,g   Verweij, Niek ^a   Van Der Harst, Pim ^a,h  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c 23andMe Inc ^*  (United States)

^d DECODE GENETICS   (Iceland)

^e UNIVERSITY OF ICELAND   (Iceland)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEOXYRIBONUCLEASE I;

ADRENAL GLAND; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BASAL METABOLIC RATE; BIOINFORMATICS; BODY MASS; BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR TISSUE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FETUS HEART; GENDER; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HERITABILITY; HUMAN; HYPERTENSION; ICD-10; INCIDENCE; LIFE EXPECTANCY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PHENOTYPE; PLEIOTROPY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RESTING HEART RATE; SMOKING; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; ARRHYTHMIAS, CARDIAC; GENETIC VARIATION; GENETICS; GENOMICS; HEART RATE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REST; RISK FACTOR; SURVIVAL RATE;

ARRHYTHMIAS, CARDIAC; FEMALE; GENETIC LOCI; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HEART RATE; HUMANS; MALE; MIDDLE AGED; REST; RISK FACTORS; SURVIVAL RATE;

EID: 84992718268     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3708     Document Type: Article

References (39)

1. Schmidt-Nielsen, K. Animal Physiology: Adaptation and Environment (Cambridge University Press, 1975
2. Levine, H.J. Rest heart rate and life expectancy. J. Am. Coll. Cardiol. 30, 1104-1106 (1997
3. Dyer, A.R. et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am. J. Epidemiol. 112, 736-749 (1980
4. Kannel, W.B., Kannel, C., Paffenbarger, R.S. Jr. & Cupples, L.A. Heart rate and cardiovascular mortality: the Framingham Study. Am. Heart J. 113, 1489-1494 (1987
5. Gillum, R.F., Makuc, D.M. & Feldman, J.J. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up Study. Am. Heart J. 121, 172-177 (1991
6. Greenland, P. et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am. J. Epidemiol. 149, 853-862 (1999
7. Kristal-Boneh, E., Silber, H., Harari, G. & Froom, P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur. Heart J. 21, 116-124 (2000
8. Reunanen, A. et al. Heart rate and mortality. J. Intern. Med. 247, 231-239 (2000
9. Kolloch, R. et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/trandolapril Study (INVEST). Eur. Heart J. 29, 1327-1334 (2008
10. Diaz, A., Bourassa, M.G., Guertin, M.C. & Tardif, J.C. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur. Heart J. 26, 967-974 (2005
11. Böhm, M. et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376, 886-894 (2010
12. Grassi, G. et al. Heart rate as marker of sympathetic activity. J. Hypertens. 16, 1635-1639 (1998
13. Böhm, M., Reil, J.C., Deedwania, P., Kim, J.B. & Borer, J.S. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am. J. Med. 128, 219-228 (2015
14. Aladin, A.I. et al. The association of resting heart rate and incident hypertension: the Henry Ford Hospital Exercise Testing (FIT) Project. Am. J. Hypertens. 29, 251-257 (2016
15. Jiang, X. et al. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study. Heart 101, 44-49 (2015
16. Caetano, J. & Delgado Alves, J. Heart rate and cardiovascular protection. Eur. J. Intern. Med. 26, 217-222 (2015
17. Bangalore, S. et al. β-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. J. Am. Med. Assoc. 308, 1340-1349 (2012
18. Messerli, F.H., Grossman, E. & Goldbourt, U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. J. Am. Med. Assoc. 279, 1903-1907 (1998
19. Van Gelder, I.C. et al. Lenient versus strict rate control in patients with atrial fibrillation. N. Engl. J. Med. 362, 1363-1373 (2010
20. Fox, K. et al. Ivabradine in stable coronary artery disease without clinical heart failure. N. Engl. J. Med. 371, 1091-1099 (2014
21. Swedberg, K. et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875-885 (2010
22. Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015
23. den Hoed, M. et al. Identification of heart rate-Associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45, 621-631 (2013
24. Pers, T.H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015
25. Siva, N. UK gears up to decode 100,000 genomes from NHS patients. Lancet 385, 103-104 (2015
26. Collins, F.S. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 372, 793-795 (2015
27. Fox, K., Ford, I., Steg, P.G., Tendera, M. & Ferrari, R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372, 807-816 (2008
28. Azbel, MYa. Universal biological scaling and mortality. Proc. Natl. Acad. Sci. USA 91, 12453-12457 (1994
29. Davies, G. et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112151). Mol. Psychiatry 21, 758-767 (2016
30. Lane, J.M. et al. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat. Commun. 7, 10889 (2016
31. Xu, C. et al. Estimating genome-wide significance for whole-genome sequencing studies. Genet. Epidemiol. 38, 281-290 (2014
32. Kanai, M., Tanaka, T. & Okada, Y. Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set. J. Hum. Genet. http://dx.doi.org/10.1038/jhg.2016.72 (2016
33. UK Biobank. Genotype imputation and genetic association studies of UK Biobank. Interim data release, May 2015 http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/imputation-documentation-May2015.pdf (2015
34. UK Biobank. Genotyping and quality control of UK Biobank, a largescale, extensively phenotyped prospective resource. Information for researchers. Interim Data Release, 2015. http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UKBiobank-genotyping-QC-documentation-web.pdf (2015
35. Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009
36. Thanassoulis, G. et al. Genetic associations with valvular calcification and aortic stenosis. N. Engl. J. Med. 368, 503-512 (2013
37. Nelson, C.P. et al. Genetically determined height and coronary artery disease. N. Engl. J. Med. 372, 1608-1618 (2015
38. Burgess, S. & Thompson, S.G. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol. 181, 251-260 (2015
39. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512-525 (2015).